Key result
Angiotensin-receptor blocker recalls expose critical issues in health system readiness, patient-provider trust, uncertain drug-dose equivalences, and global drug manufacturing regulation.
Design
Editorial
Authors
Loading...
Highlights systemic issues in health system readiness, patient trust, and global manufacturing regulation exposed by the recalls of angiotensin-receptor blockers.
Key points are not available for this paper at this time.
Byrd et al. (2019) studied this question. Angiotensin-receptor blocker recalls expose critical issues in health system readiness, patient-provider trust, uncertain drug-dose equivalences, and global drug manufacturing regulation.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: